Skip to main content
logo
Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
2.400
-0.062 (-2.52%)
Mar 20, 2026, 4:00 PM EDT - Market closed

UPC Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
17,85923,02432,30940.1447.98
Revenue Growth (YoY)
-22.44%-28.74%80383.80%-16.34%56.27%
Cost of Revenue
-11,558-16,953-21,994-18.25-22.66
Gross Profit
6,3016,07210,31521.8925.33
Selling, General & Admin
-8,545-11,061-9,423-21.27-6.27
Research & Development
-671.76-3,031-4,859-7.64-5.47
Total Operating Expenses
-9,217-14,092-14,281-28.91-11.74
Operating Income
-2,916-8,020-3,966-7.0213.59
Interest Income
65.0631.9431.070.040.27
Interest Expense
-232.04-278.17-156.79-0.16-0.1
Other Non-Operating Income (Expense)
-589.15145.48-235.610.05-0.08
Total Non-Operating Income (Expense)
-756.14-100.75-361.33-0.070.09
Pretax Income
-3,672-8,121-4,327-7.0913.68
Provision for Income Taxes
--606.7-2,254-0.82-2.36
Net Income
-3,672-8,727-6,581-7.9111.32
Net Income to Common
-3,672-8,727-6,581-7.9111.32
Net Income Growth
----49.77%
Shares Outstanding (Basic)
00000
Shares Outstanding (Diluted)
00000
Shares Change (YoY)
3174.93%130.39%-14.60%18.63%
EPS (Basic)
-8.06-626.96-1089.21-1309.112148.00
EPS (Diluted)
-8.06-626.96-1089.21-1309.112148.00
EPS Growth
----26.95%
Free Cash Flow
-5,319-9,7521,073-1.39-15.59
Free Cash Flow Per Share
-11667.97-700609.27177524.99-230.84-2956.32
Gross Margin
35.28%26.37%31.93%54.53%52.78%
Operating Margin
-16.33%-34.83%-12.28%-17.49%28.32%
Profit Margin
-20.56%-32.63%-6.42%-15.64%33.42%
FCF Margin
-29.78%-42.36%3.32%-3.47%-32.49%
EBITDA
-2,398-7,534-3,457-6.4914.04
EBITDA Margin
-13.43%-32.72%-10.70%-16.16%29.25%
EBIT
-2,916-8,020-3,966-7.0213.59
EBIT Margin
-16.33%-34.83%-12.28%-17.49%28.32%
Effective Tax Rate
0.00%7.47%52.08%11.49%-17.24%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q